Kaitlyn Melanie Arsenault serves as Executive at Skye Bioscience, Inc., where they oversee executive responsibilities. Since joining the company, Kaitlyn Melanie Arsenault has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 14, 2021 involved receiving (via award) 1,000,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 14, 2021 | SKYE | $0 | Award | 1,000,000 | $N/A | Discretionary |
Kaitlyn Melanie Arsenault currently holds 1,000,000 shares of Skye Bioscience, Inc. (SKYE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kaitlyn Melanie Arsenault has been a net neutral trader of SKYE stock. They have purchased $0 and sold $0 worth of shares.
Kaitlyn Melanie Arsenault's most recent insider trade was on Dec 14, 2021, when they sold 1,000,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted